← Back to headlines
Psyence BioMed Welcomes US Executive Action on Ibogaine Research
Psyence BioMed has expressed its support for recent U.S. executive action aimed at advancing research into Ibogaine.
17 Apr, 13:15 — 17 Apr, 13:15
Sources
Showing 1 of 1 sources
Related Stories
Trump Renames Lake Ontario as Lake America Amid Trade Tensions
13m ago
Greece Denies Claims That New Tourism Plan Allows Coastal Building Near Shoreline
17m ago
French Presidential Candidates Clash in First Debate Ahead of 2027 Vote
19m ago
Quebec Launches Provincial Election Campaign Amid Separatist Poll Leads
25m ago